查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到 2030 年心臟去颤器市场预测：按类型、患者类型、最终用户和地区分類的全球分析
市场调查报告书
商品编码
1372019

到 2030 年心臟去颤器市场预测：按类型、患者类型、最终用户和地区分類的全球分析

Defibrillator Market Forecasts to 2030 - Global Analysis By Type (Implantable Cardioverter Defibrillators and External Defibrillators), Patient Type (Adult and Pediatric), End User and By Geography.
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球心臟去颤器市场规模为 154.9 亿美元，预计在预测期内将以 8.6% 的年复合成长率增长，到 2030 年达到 275 亿美元。

心臟去颤器是医疗设备，旨在向心臟提供电击以恢復正常心率，特别是在发生危及生命的心室心搏过速）的情况下。这些异常的心律会导致心臟颤抖或快速跳动，导致心臟麻痹。心臟去颤器对于立即治疗至关重要，它可以透过电击帮助心臟恢復正常节律并改善全身的血液循环。心臟去颤器广泛应用于医院、心臟监护室、急诊室和手术室，以管理心律不整并快速回应心臟紧急情况。

根据冠状动脉疾病基金会 2022 年发布的报告，美国年度报告约 356,000 例院外心臟麻痹(OHCA)。

目标疾病发生率增加

世界上很大一部分人口受到冠状动脉疾病和心臟麻痹等心血管疾病的影响。冠状动脉疾病更可能导致心律不整性心因性猝死。肥胖、高血压、血脂异常症和糖尿病等生活型态因素会增加多种心血管疾病的风险。此外，导致CVD患病增加的一个主要要素是世界老年人口的增加。由于心臟结构和功能逐渐恶化和复杂化，老龄化使室心室心律不整的发生急剧增加，导致心臟心律不整的患病增加。所有这些要素预计将推动对心臟去颤器的需求，这些设备可以在心臟紧急情况下提供及时介入。

成本和承受能力

心臟去颤器可能非常昂贵，特别是对于具有增强功能和性能的高级型号。这种高成本给资源有限的医疗保健提供者、设施和社区带来了挑战，限制了他们投资救生设备的能力。此外，负担能力阻碍了普及和可近性，阻碍了在公共场所和医疗机构安装心臟去颤器的配合措施。解决成本障碍对于确保更广泛的可用性和利用至关重要，特别是在服务不足的社区和资源有限的医疗保健系统中。

世界高龄化

随着世界人口老化，心臟疾病的发病率和心臟麻痹（SCA）的风险不断增加。拥有心臟去颤器对老年人来说最重要，因为高龄化通常与多种心臟病有关。在心臟紧急情况下，心臟去颤器对于心臟復苏至关重要，可以大大增加生存机会。由于老年人更容易患心臟病，因此老年护理机构、疗养院、福利设施和家庭护理中越来越需要心臟去颤器。此外，由于心臟去颤器技术的进步，包括专门为满足老年人口的需求而製造的设备，心臟去颤器变得越来越普及和广泛使用。製造商正在投资研究开发适合年龄的心臟去颤器解决方案，以满足老年人的独特需求，并提供符合世界人口向高龄化社会转变的有前景的解决方案，创造市场机会。

科技颠覆与创新

科技颠覆和创新对心臟去颤器市场构成重大威胁。医疗技术的快速进步，包括小型化、人工智慧、连接性和先进材料，可能会使当前的心臟去颤器型号过时或竞争下降。穿戴式和连接技术可以彻底改变心臟监测和紧急应变，减少对传统心臟去颤器的需求。此外，再生医学和生物工程的突破可能透过专注于心臟组织的再生和修復来提供心臟去颤器的替代品。如果未能跟上这些技术创新的步伐，可能会导致市场占有率下降并减少对传统心臟去颤器的需求。

COVID-19 的影响

COVID-19大流行预计将对全球心臟去颤器市场的成长产生负面影响。疫情损害了医院，尤其是小型医院的购买力，导致供应交易和程序取消和推迟，影响了所有主要心臟去颤器市场竞争的整体收入。世界各地的医疗保健系统必须处理的主要问题是后勤问题、疾病管理、优先照顾患有合併症和既有疾病的患者，以及公众和医院一线工作人员的需求。进一步保护人们免受COVID-19 的侵害。商品和服务的交付速度也受到各国最近实施的包装法规和封锁程序的影响。心臟去颤器市场製造和供应链受到这些问题的负面影响。

植入式心臟整流去颤器市场预计将在预测期内成为最大的市场

据估计，植入式心臟整流去颤器市场占最大份额。植入式心臟整流去颤器(ICD) 是一种植入式医疗设备，旨在监测和管理心律不整，特别是心室心律不整。由于心臟疾病患病的增加和人口高龄化的加剧，ICD 市场正在经历显着增长。 ICD 可解决一级预防（对于有发生危及生命的心律不整风险的人）和二级预防（对于已经经历过心臟事件的人）的问题。此外，技术的进步带来了更小、更复杂的 ICD，具有远端监控和针对心搏过缓患者的整合起搏器等功能。此外，ICD 在治疗心律不整、改善患者生活品质和降低死亡率方面继续发挥关键作用，使其成为心臟去颤器市场的关键结构要素。因此，心臟去颤器市场预计将出现良好的成长。

医院、诊所和心臟中心部门预计在预测期内将经历最高的年复合成长率。

预计医院、诊所和心臟中心领域将在预测期内出现良好成长。医院、诊所和心臟中心对于心臟去颤器的采用、使用和分发至关重要。这些是初级护理点，心臟去颤器对于治疗心臟麻痹(SCA) 和其他危及生命的心律不整至关重要。在医院和心臟中心，心臟去颤器是急诊室、重症监护室、心导管实验室和手术室的重要组成部分。此外，许多诊所和公共卫生保健中心都备有自动体外心臟去颤器（AED），可用于应对机构内或週边地区发生的心臟事件。在这些情况下，去心房颤动。确保医院、诊所和心臟中心心臟去颤器的可用性和可及性对于挽救生命和改善心臟治疗结果仍然至关重要。因此，它正在支持该领域的成长。

比最大的地区

由于美国和加拿大主要企业的倡议、有利的法规以及技术先进的医疗设施，北美在预测期内占据了最大的市场占有率。 2022 年，北美地区的收益占有率最大，超过 42.2%。例如，波士顿科学公司表示，到年终，该公司已在全球部署了约 33,000 台 CRT-D 系列的 Autogen、Incepta、Resonate、Cognis 和 Dynagen 设备。其中，光在美国就有 16,500 个註册，普及强劲。由于该地区医疗设施高度发展以及研发活动支出不断增加，美国在心臟去颤器市场占据主导地位。此外，体外心臟去颤器不仅越来越多地安装在医院，而且越来越多地安装在学校、酒店、道路和火车站等公共场所，以防止心臟麻痹。 ，这是心臟去颤器占有率高的一个主要要素北美市场。

复合年复合成长率最高的地区：

由于患者人数增加、医疗基础设施扩大以及冠心病发病率高，预计亚太地区在预测期内将出现盈利增长。普及心臟去颤器的高普及率和日本的支持政策正在支持区域扩张。此外，随着该地区患者群体的扩大以及公众对公共心臟去颤器认知度的提高，随着基础设施支出和心臟去颤器普及的提高，该地区的市场开拓将会加速。此外，像日本这样的国家，由于存在着专注于拓展其他地区市场的大公司，心臟去颤器的普及很高，这也有可能扩大全球心臟去颤器市场。

提供免费客製化：

如果您订阅此报告，我们将为您提供以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球心臟去颤器市场：按类型

  • 植入式心臟整流去颤器
  • 体外心臟去颤器

第6章全球心臟去颤器市场：依患者类型

  • 成人
  • 儿童

第7章全球心臟去颤器市场：依最终用户分类

  • 医院、诊所、心臟中心
  • 公共准入市场
  • 替代护理设施
  • 设置院前护理
  • 居家护理
  • 门诊手术中心
  • 其他最终用户

第8章全球心臟去颤器市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第9章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第10章公司简介

  • Abbott Laboratories, Inc.
  • Medtronic
  • MicroPort Scientific Corporation
  • Boston Scientific Corporation
  • ZOLL Medical Corporation
  • Schiller AG
  • Nihon Kohden Corporation
  • StrykerCorporation
  • PhilipsHealthcare
  • CardiacScienceCorporation
  • LivaNovaPLC
  • Asahi Kasei Corporation
  • Biotronik
  • CU Medical System Inc.
  • Koninklijke Philips NV
  • Metrax GmbH
  • Progetti srl
  • Defibtech LLC
  • HeartSine Technologies LLC.
  • Mindray Medical International Limited
Product Code: SMRC24075

According to Stratistics MRC, the Global Defibrillator Market is accounted for $15.49 billion in 2023 and is expected to reach $27.50 billion by 2030 growing at a CAGR of 8.6% during the forecast period. Defibrillators are medical devices designed to deliver an electric shock to the heart in order to restore a normal heartbeat, especially during life-threatening cardiac arrhythmias like ventricular fibrillation or ventricular tachycardia. These abnormal heart rhythms can cause the heart to quiver or beat too fast, leading to cardiac arrest. Defibrillators are vital in providing immediate treatment by administering an electric shock, which helps the heart re-establish a regular rhythm and improves blood circulation throughout the body. Defibrillators are extensively used in hospitals, cardiac care units, emergency rooms, and operating rooms to manage cardiac arrhythmias and to provide rapid response in case of cardiac emergencies.

According to the report published by the Coronary Artery Disease Foundation in 2022, around 356,000 out-of-hospital cardiac arrests (OHCA) are reported annually in the US.

Market Dynamics:

Driver:

Increasing incidence of the target disorders

A significant portion of the global population are impacted by cardiovascular diseases such coronary artery disease and cardiac arrest. Arrhythmic sudden cardiac death is more likely as a result of coronary artery disease. The risk of acquiring numerous cardiovascular illnesses is mostly increased by lifestyle conditions such obesity, hypertension, dyslipidemia, and diabetes. In addition, a significant contributor in the increased prevalence of CVD is the growing worldwide elderly population. Due to the gradual deterioration and increase in complexity in the structure and function of the heart, ageing is connected with an exponential rise in the development of ventricular arrhythmias, resulting in an increase in the prevalence of arrhythmias in the heart. All these factors are anticipated to propel the demand for defibrillators to provide timely intervention with these devices during cardiac emergencies.

Restraint:

Cost and Affordability

Defibrillator devices can be prohibitively expensive, especially advanced models with enhanced features and capabilities. This high cost poses a challenge for healthcare providers, facilities, and regions with constrained financial resources, limiting their ability to invest in these life-saving devices. Additionally, affordability concerns hinder widespread adoption and accessibility, hampering efforts to equip public spaces and healthcare institutions with defibrillators. Addressing cost barriers is crucial to ensuring broader availability and utilisation, particularly in underserved communities and resource-constrained healthcare systems.

Opportunity:

Global Aging Population

The incidence of cardiac diseases and the risk of sudden cardiac arrest (SCA) rise along with an increase in the number of elderly people worldwide. Defibrillator adoption is of the utmost importance for the senior population because ageing is typically accompanied by a variety of cardiac issues. In cardiac emergencies, defibrillators are essential for reviving the heart, greatly increasing the likelihood of survival. Defibrillators are becoming more necessary in geriatric care settings, nursing homes, assisted living facilities, and at-home care since the elderly are more prone to cardiac episodes. Moreover, defibrillators are becoming more popular and widely used due to developments in defibrillator technology, such as devices made specifically to meet the demands of the senior population. Manufacturers are investing in research to develop age-appropriate defibrillator solutions to meet the distinct requirements of older individuals, creating a promising market opportunity that aligns with the global demographic shift towards an ageing society.

Threat:

Technological Disruption and Innovation

Technological disruption and innovation pose a significant threat to the defibrillator market. The rapid evolution of medical technology, encompassing miniaturization, artificial intelligence, connectivity, and advanced materials, has the potential to render current defibrillator models obsolete or less competitive. Wearable and connected technologies might revolutionize cardiac monitoring and emergency response, potentially reducing the need for traditional defibrillators. Furthermore, breakthroughs in regenerative medicine and bioengineering could offer alternatives to defibrillators by focusing on cardiac tissue regeneration and repair. Failure to keep pace with these innovations could result in declining market share and diminished demand for traditional defibrillators.

COVID-19 Impact

The COVID-19 outbreak is anticipated to have a negative impact on the growth of the global defibrillator market. The pandemic damaged hospitals' purchasing power, especially minor hospitals, which led to cancelled or postponed supply deals and procedures, which had an effect on the overall income of all the major defibrillator market competitors. The main issues that healthcare systems around the world had to deal with were logistical issues, sickness management, giving priority to patients with comorbidities and pre-existing problems, and further protecting the general public and hospital frontline workers from COVID-19. The speed of delivery of goods and services was also impacted by more recent packaging restrictions and country-imposed lockdown processes. The manufacturing and supply chain for the defibrillator market are adversely affected by each of these issues.

The Implantable Cardioverter Defibrillators segment is expected to be the largest during the forecast period

The Implantable Cardioverter Defibrillators segment is estimated to hold the largest share. Implantable Cardioverter Defibrillators (ICDs) are implantable medical devices designed to monitor and manage irregular heart rhythms, specifically ventricular arrhythmias. The ICD market has experienced significant growth due to the increasing prevalence of cardiac conditions and a growing ageing population. It caters to both primary prevention (for individuals at risk of developing life-threatening arrhythmias) and secondary prevention (for those who have already experienced cardiac events). Moreover, due to the technological advancements it has smaller and more sophisticated ICDs, with features like remote monitoring and integrated pacemakers for bradycardia patients. Additionally, ICDs continue to play a critical role in managing cardiac arrhythmias, improving patient quality of life, and reducing mortality rates, making them a key component of the defibrillator market. Therefore, there is lucrative growth for the defibrillator market.

The Hospitals, Clinics and Cardiac Centres segment is expected to have the highest CAGR during the forecast period

The Hospitals, Clinics and Cardiac Centres segment is anticipated to have lucrative growth during the forecast period. Hospitals, clinics, and cardiac centres are crucial in the adoption, utilisation, and distribution of defibrillators. They serve as primary points of care where defibrillators are essential in treating sudden cardiac arrest (SCA) and other life-threatening arrhythmias. In hospitals and cardiac centres, defibrillators are integral components of emergency rooms, critical care units, cardiac catheterization labs, and operating rooms. Additionally, many clinics and public healthcare centres have AEDs readily accessible to respond to cardiac events in their facilities or surrounding areas. Proper training and education regarding defibrillator usage are essential in these settings to enhance the efficacy and impact of defibrillation efforts. Ensuring the availability and accessibility of defibrillators in hospitals, clinics, and cardiac centres remains paramount to saving lives and improving cardiac care outcomes. Thus, it is propelling segment growth.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to initiatives by key players, favourable regulations, and technologically advanced healthcare facilities in the U.S. and Canada. North America held the largest revenue share of more than 42.2% in 2022. For instance, Boston Scientific stated that by the end of 2020, it had deployed about 33,000 Autogen, Incepta, Resonate, Cognis, and Dynagen devices from its CRT-Ds line globally. A strong adoption rate can be seen in the fact that 16,500 of these were registered in the U.S. alone. It dominates the defibrillator market because of the prevailing sophisticated level of healthcare facilities and rising expenditure for research and development activities in this region. Additionally, growing installations of external defibrillators in hospitals as well as in public places such as schools, hotels, streets, railway stations, and others with the aim of preventing fatalities from sudden cardiac arrest is prominently responsible for holding a higher defibrillator market share in North America.

Region with highest CAGR:

Asia-Pacific region is expected to witness profitable growth over the projection period, due to an increasing patient population, an expanding healthcare infrastructure, and the frequency of coronary diseases. A high defibrillator penetration rate and supportive policies in Japan are boosting regional expansion. Additionally, as a result of the region's expanding patient base and growing public awareness of public-access defibrillators, the market in this area will experience faster development as infrastructure spending and defibrillator penetration rise. Moreover, countries such as Japan have a high penetration of defibrillators due to the presence of giant companies that are focused on expanding the market in other geographies, which is also likely to augment the global defibrillator market.

Key players in the market

Some of the key players in the Defibrillator Market include: Abbott Laboratories, Inc., Medtronic, MicroPort Scientific Corporation, Boston Scientific Corporation, ZOLL Medical Corporation, Schiller AG, Nihon Kohden Corporation, StrykerCorporation, PhilipsHealthcare, CardiacScienceCorporation, LivaNovaPLC, Asahi Kasei Corporation, Biotronik, CU Medical System Inc., Koninklijke Philips N.V., Metrax GmbH, Progetti srl, Defibtech LLC, HeartSine Technologies LLC and Mindray Medical International Limited.

Key Developments:

In December 2022, Abbott Launches Navitor™, Its Latest-Generation Transcatheter Aortic Valve Implantation (Tavi) System To Treat Aortic Stenosis In India. Global healthcare company, Abbott announced that it has launched its latest-generation transcatheter aortic valve implantation (TAVI) system, NavitorTM, making the minimally invasive device available for people in India with severe aortic stenosis who are at high or extreme surgical risk.

In September 2022, Abbott Launches New Ensure With Hmb To Help Protect And Strengthen Indian Adults' Muscles. The new Ensure with HMB and 32 nutrients is a clinically-tested, science-based nutritional supplement specially designed to protect and strengthen muscles.

In July 2022, Abbott Launches Grow Right 2.0 Highlighting The Right M-E-A-N-S To Help Parents Foster Holistic Growth In Children. Abbott has launched its Grow Right 2.0 charter introducing M-E-A-N-S guidelines for good practices in Measuring growth, Eating, Activity, Nurturing and Sleep. Abbott's Grow Right 2.0 Charter can help parents address concerns with expert-backed guidelines to help encourage healthy habits in children

Types Covered:

  • Implantable Cardioverter Defibrillators
  • External Defibrillators

Patient Types Covered:

  • Adult
  • Pediatric

End Users Covered:

  • Hospitals, Clinics and Cardiac Centres
  • Public Access Markets
  • Alternate Care Facilities
  • Pre-hospital Care Settings
  • Home Care
  • Ambulatory Surgical Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Defibrillator Market, By Type

  • 5.1 Introduction
  • 5.2 Implantable Cardioverter Defibrillators
  • 5.3 External Defibrillators

6 Global Defibrillator Market, By Patient Type

  • 6.1 Introduction
  • 6.2 Adult
  • 6.3 Pediatric

7 Global Defibrillator Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals, Clinics and Cardiac Centres
  • 7.3 Public access Markets
  • 7.4 Alternate Care Facilities
  • 7.5 Pre-hospital Care Settings
  • 7.6 Home Care
  • 7.7 Ambulatory Surgical Centers
  • 7.8 Other End Users

8 Global Defibrillator Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories, Inc.
  • 10.2 Medtronic
  • 10.3 MicroPort Scientific Corporation
  • 10.4 Boston Scientific Corporation
  • 10.5 ZOLL Medical Corporation
  • 10.6 Schiller AG
  • 10.7 Nihon Kohden Corporation
  • 10.8 StrykerCorporation
  • 10.9 PhilipsHealthcare
  • 10.10 CardiacScienceCorporation
  • 10.11 LivaNovaPLC
  • 10.12 Asahi Kasei Corporation
  • 10.13 Biotronik
  • 10.14 CU Medical System Inc.
  • 10.15 Koninklijke Philips N.V.
  • 10.16 Metrax GmbH
  • 10.17 Progetti srl
  • 10.18 Defibtech LLC
  • 10.19 HeartSine Technologies LLC.
  • 10.20 Mindray Medical International Limited

List of Tables

  • Table 1 Global Defibrillator Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Defibrillator Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Defibrillator Market Outlook, By Implantable Cardioverter Defibrillators (2021-2030) ($MN)
  • Table 4 Global Defibrillator Market Outlook, By External Defibrillators (2021-2030) ($MN)
  • Table 5 Global Defibrillator Market Outlook, By Patient Type (2021-2030) ($MN)
  • Table 6 Global Defibrillator Market Outlook, By Adult (2021-2030) ($MN)
  • Table 7 Global Defibrillator Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 8 Global Defibrillator Market Outlook, By End User (2021-2030) ($MN)
  • Table 9 Global Defibrillator Market Outlook, By Hospitals, Clinics and Cardiac Centres (2021-2030) ($MN)
  • Table 10 Global Defibrillator Market Outlook, By Public access Markets (2021-2030) ($MN)
  • Table 11 Global Defibrillator Market Outlook, By Alternate Care Facilities (2021-2030) ($MN)
  • Table 12 Global Defibrillator Market Outlook, By Pre-hospital Care Settings (2021-2030) ($MN)
  • Table 13 Global Defibrillator Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 14 Global Defibrillator Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 15 Global Defibrillator Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 16 North America Defibrillator Market Outlook, By Country (2021-2030) ($MN)
  • Table 17 North America Defibrillator Market Outlook, By Type (2021-2030) ($MN)
  • Table 18 North America Defibrillator Market Outlook, By Implantable Cardioverter Defibrillators (2021-2030) ($MN)
  • Table 19 North America Defibrillator Market Outlook, By External Defibrillators (2021-2030) ($MN)
  • Table 20 North America Defibrillator Market Outlook, By Patient Type (2021-2030) ($MN)
  • Table 21 North America Defibrillator Market Outlook, By Adult (2021-2030) ($MN)
  • Table 22 North America Defibrillator Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 23 North America Defibrillator Market Outlook, By End User (2021-2030) ($MN)
  • Table 24 North America Defibrillator Market Outlook, By Hospitals, Clinics and Cardiac Centres (2021-2030) ($MN)
  • Table 25 North America Defibrillator Market Outlook, By Public access Markets (2021-2030) ($MN)
  • Table 26 North America Defibrillator Market Outlook, By Alternate Care Facilities (2021-2030) ($MN)
  • Table 27 North America Defibrillator Market Outlook, By Pre-hospital Care Settings (2021-2030) ($MN)
  • Table 28 North America Defibrillator Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 29 North America Defibrillator Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 30 North America Defibrillator Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 31 Europe Defibrillator Market Outlook, By Country (2021-2030) ($MN)
  • Table 32 Europe Defibrillator Market Outlook, By Type (2021-2030) ($MN)
  • Table 33 Europe Defibrillator Market Outlook, By Implantable Cardioverter Defibrillators (2021-2030) ($MN)
  • Table 34 Europe Defibrillator Market Outlook, By External Defibrillators (2021-2030) ($MN)
  • Table 35 Europe Defibrillator Market Outlook, By Patient Type (2021-2030) ($MN)
  • Table 36 Europe Defibrillator Market Outlook, By Adult (2021-2030) ($MN)
  • Table 37 Europe Defibrillator Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 38 Europe Defibrillator Market Outlook, By End User (2021-2030) ($MN)
  • Table 39 Europe Defibrillator Market Outlook, By Hospitals, Clinics and Cardiac Centres (2021-2030) ($MN)
  • Table 40 Europe Defibrillator Market Outlook, By Public access Markets (2021-2030) ($MN)
  • Table 41 Europe Defibrillator Market Outlook, By Alternate Care Facilities (2021-2030) ($MN)
  • Table 42 Europe Defibrillator Market Outlook, By Pre-hospital Care Settings (2021-2030) ($MN)
  • Table 43 Europe Defibrillator Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 44 Europe Defibrillator Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 45 Europe Defibrillator Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 46 Asia Pacific Defibrillator Market Outlook, By Country (2021-2030) ($MN)
  • Table 47 Asia Pacific Defibrillator Market Outlook, By Type (2021-2030) ($MN)
  • Table 48 Asia Pacific Defibrillator Market Outlook, By Implantable Cardioverter Defibrillators (2021-2030) ($MN)
  • Table 49 Asia Pacific Defibrillator Market Outlook, By External Defibrillators (2021-2030) ($MN)
  • Table 50 Asia Pacific Defibrillator Market Outlook, By Wearable Cardioverter Defibrillators (2021-2030) ($MN)
  • Table 51 Asia Pacific Defibrillator Market Outlook, By Manual External Defibrillators (2021-2030) ($MN)
  • Table 52 Asia Pacific Defibrillator Market Outlook, By Wearable Cardioverter Defibrillators (2021-2030) ($MN)
  • Table 53 Asia Pacific Defibrillator Market Outlook, By Automated External Defibrillator (2021-2030) ($MN)
  • Table 54 Asia Pacific Defibrillator Market Outlook, By Semi-Automated External Defibrillator (2021-2030) ($MN)
  • Table 55 Asia Pacific Defibrillator Market Outlook, By Patient Type (2021-2030) ($MN)
  • Table 56 Asia Pacific Defibrillator Market Outlook, By Adult (2021-2030) ($MN)
  • Table 57 Asia Pacific Defibrillator Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 58 Asia Pacific Defibrillator Market Outlook, By End User (2021-2030) ($MN)
  • Table 59 Asia Pacific Defibrillator Market Outlook, By Hospitals, Clinics and Cardiac Centres (2021-2030) ($MN)
  • Table 60 Asia Pacific Defibrillator Market Outlook, By Public access Markets (2021-2030) ($MN)
  • Table 61 Asia Pacific Defibrillator Market Outlook, By Alternate Care Facilities (2021-2030) ($MN)
  • Table 62 Asia Pacific Defibrillator Market Outlook, By Pre-hospital Care Settings (2021-2030) ($MN)
  • Table 63 Asia Pacific Defibrillator Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 64 Asia Pacific Defibrillator Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 65 Asia Pacific Defibrillator Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 66 South America Defibrillator Market Outlook, By Country (2021-2030) ($MN)
  • Table 67 South America Defibrillator Market Outlook, By Type (2021-2030) ($MN)
  • Table 68 South America Defibrillator Market Outlook, By Implantable Cardioverter Defibrillators (2021-2030) ($MN)
  • Table 69 South America Defibrillator Market Outlook, By External Defibrillators (2021-2030) ($MN)
  • Table 70 South America Defibrillator Market Outlook, By Patient Type (2021-2030) ($MN)
  • Table 71 South America Defibrillator Market Outlook, By Adult (2021-2030) ($MN)
  • Table 72 South America Defibrillator Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 73 South America Defibrillator Market Outlook, By End User (2021-2030) ($MN)
  • Table 74 South America Defibrillator Market Outlook, By Hospitals, Clinics and Cardiac Centres (2021-2030) ($MN)
  • Table 75 South America Defibrillator Market Outlook, By Public access Markets (2021-2030) ($MN)
  • Table 76 South America Defibrillator Market Outlook, By Alternate Care Facilities (2021-2030) ($MN)
  • Table 77 South America Defibrillator Market Outlook, By Pre-hospital Care Settings (2021-2030) ($MN)
  • Table 78 South America Defibrillator Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 79 South America Defibrillator Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 80 South America Defibrillator Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 81 Middle East & Africa Defibrillator Market Outlook, By Country (2021-2030) ($MN)
  • Table 82 Middle East & Africa Defibrillator Market Outlook, By Type (2021-2030) ($MN)
  • Table 83 Middle East & Africa Defibrillator Market Outlook, By Implantable Cardioverter Defibrillators (2021-2030) ($MN)
  • Table 84 Middle East & Africa Defibrillator Market Outlook, By External Defibrillators (2021-2030) ($MN)
  • Table 85 Middle East & Africa Defibrillator Market Outlook, By Patient Type (2021-2030) ($MN)
  • Table 86 Middle East & Africa Defibrillator Market Outlook, By Adult (2021-2030) ($MN)
  • Table 87 Middle East & Africa Defibrillator Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 88 Middle East & Africa Defibrillator Market Outlook, By End User (2021-2030) ($MN)
  • Table 89 Middle East & Africa Defibrillator Market Outlook, By Hospitals, Clinics and Cardiac Centres (2021-2030) ($MN)
  • Table 90 Middle East & Africa Defibrillator Market Outlook, By Public access Markets (2021-2030) ($MN)
  • Table 91 Middle East & Africa Defibrillator Market Outlook, By Alternate Care Facilities (2021-2030) ($MN)
  • Table 92 Middle East & Africa Defibrillator Market Outlook, By Pre-hospital Care Settings (2021-2030) ($MN)
  • Table 93 Middle East & Africa Defibrillator Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 94 Middle East & Africa Defibrillator Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 95 Middle East & Africa Defibrillator Market Outlook, By Other End Users (2021-2030) ($MN)